AMBER DEVIRGILIIS: Open Payments
NPI 1205121571 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118 in 4 payments from 4 companies in 2025. Trend: 2023 $128 · 2024 $207 · 2025 $118
Food & beverage: $118
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $46 |
| BIOTRONIK INC. | 1 | $31 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: ENROUTE Transcarotid Neuroprotection System, BIOMONITOR, VYNDAQEL, FARXIGA.
Industry payments across PA — which companies pay providers there.
